Treatment of chronic infections with rifamycins: is resistance likely to follow?

Antimicrob Agents Chemother. 2003 Oct;47(10):3037-9. doi: 10.1128/AAC.47.10.3037-3039.2003.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Antitubercular Agents / pharmacology
  • Bacterial Infections / drug therapy*
  • Chronic Disease
  • Drug Resistance, Bacterial
  • Drug Resistance, Multiple
  • Humans
  • Rifamycins / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Antitubercular Agents
  • Rifamycins